Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
940.7 INR | -1.18% | -1.73% | +45.08% |
05-23 | Strides Pharma Science Turns to Consolidated Net Profit in Fiscal Q4; Shares Down 3% | MT |
05-22 | Transcript : Strides Pharma Science Limited, Q4 2024 Earnings Call, May 22, 2024 |
Sales 2024 | 40.51B 486M 38.39B | Sales 2025 * | 46.17B 553M 43.76B | Capitalization | 86.53B 1.04B 82.01B |
---|---|---|---|---|---|
Net income 2024 | -706M -8.46M -669M | Net income 2025 * | 4.33B 51.87M 4.1B | EV / Sales 2024 | 1.78 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.87 x |
P/E ratio 2024 |
-101
x | P/E ratio 2025 * |
19.7
x | Employees | 2,850 |
Yield 2024 * |
0.38% | Yield 2025 * |
0.37% | Free-Float | 65.55% |
Latest transcript on Strides Pharma Science Limited
1 day | -1.18% | ||
1 week | -1.73% | ||
Current month | +9.12% | ||
1 month | +9.81% | ||
3 months | +21.75% | ||
6 months | +44.26% | ||
Current year | +45.08% |
Managers | Title | Age | Since |
---|---|---|---|
Badree Komandur
CEO | Chief Executive Officer | - | 31/01/10 |
Arun N. Kumar
FOU | Founder | 63 | 27/06/90 |
Compliance Officer | - | 02/02/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arun N. Kumar
FOU | Founder | 63 | 27/06/90 |
Director/Board Member | 80 | 17/05/17 | |
Director/Board Member | 64 | 26/07/12 |
Date | Price | Change | Volume |
---|---|---|---|
27/06/24 | 940.7 | -1.18% | 7 299 |
26/06/24 | 952 | +0.76% | 12,425 |
25/06/24 | 944.8 | -0.14% | 6,469 |
24/06/24 | 946.2 | +0.21% | 5,593 |
21/06/24 | 944.2 | -0.22% | 10,668 |
Delayed Quote Bombay S.E., June 27, 2024 at 11:00 am
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.39% | 43.67B | |
+26.21% | 22.79B | |
+21.43% | 15.45B | |
+18.82% | 14.29B | |
+53.37% | 12.83B | |
-0.05% | 6.79B | |
-11.88% | 6.52B | |
-8.87% | 5.73B | |
+12.62% | 5.59B |
- Stock Market
- Equities
- STAR Stock
- STAR Stock